Role of Apollon in Human Melanoma Resistance to Antitumor Agents That Activate the Intrinsic or the Extrinsic Apoptosis Pathways
Elena Tassi(University of Milan), Andrea Anichini(Fondazione IRCCS Istituto Nazionale dei Tumori), Valentina Perotti(UPMC Hillman Cancer Center), Michèle Milella(National Cancer Institute), Soldano Ferrone(Massachusetts General Hospital), Marina Zanon(UPMC Hillman Cancer Center), Claudia Vegetti(UPMC Hillman Cancer Center), Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), Carmelo Carlo‐Stella(Humanitas University), Roberta Mortarini(Scripps Research Institute), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandra Molla(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro M. Gianni(University of Milan), Ilaria Bersani(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 29
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718